Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma
Purpose: To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis. PC and glycerophosphocholine (GPC) are involved in phospholipid...
Saved in:
Published in | Journal of magnetic resonance imaging Vol. 33; no. 4; pp. 808 - 816 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.04.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Purpose:
To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis. PC and glycerophosphocholine (GPC) are involved in phospholipid metabolism that accompanies mitosis. PC is the predominant peak in Grade 4 astrocytoma (GBM) while GPC dominates in AS2.
Materials and Methods:
We used high resolution magic angle spinning magnetic resonance spectroscopy to compare the concentrations of 10 metabolites in 41 biopsies (16 AS2 and 25 AS3) from 24 tumors. Immunohistochemistry was performed on paired biopsies to determine the cell density, Ki‐67 proliferation index, and vascular endothelial growth factor (VEGF) angiogenic marker expression.
Results:
AS3 had higher PC than AS2; however, the PC:GPC was less than 1 in all cases irrespective of tumor grade. Within tumors, GPC increased with Ki‐67 and PC and tCho increased with cell density. There was no association between any choline compound and VEGF.
Conclusion:
These data suggest that PC:GPC less than 1 is not unique to low grade glioma. Furthermore, the PC concentration that is a marker of aggressive glial tumors is not tightly linked to cell proliferation or angiogenesis in nonenhancing astrocytomas. J. Magn. Reson. Imaging 2011;33:808–816. © 2011 Wiley‐Liss, Inc. |
---|---|
Bibliography: | istex:052ADA74E9D8B6A19E30099A4A67C58E3EDC8D37 NIH - No. R01-CA116041 ArticleID:JMRI22517 ark:/67375/WNG-CRGKF010-K ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1053-1807 1522-2586 |
DOI: | 10.1002/jmri.22517 |